Search results
Results from the Health.Zone Content Network
Facts. The Supreme Court of Appeal (SCA) had set aside regulations relating to a transparent pricing system for medicines and scheduled substances. The Minister of Health, Manto Tshabalala-Msimang sought leave to appeal against that decision to the Constitutional Court. As a result of the application, both parties published conflicting ...
Minister of Health v New Clicks. New Clicks South Africa (Pty) Ltd v Tshabalala-Msimang and Another NNO; Pharmaceutical Society of South Africa and Others v Tshabalala-Msimang and Another NNO 2005 (2) SA 530 (C) is an important case in South African administrative law. However, note that this case went on appeal, first to the Supreme Court of ...
August 21, 2024 at 5:21 AM. CAPE TOWN, South Africa (AP) — Congo reported more than 1,000 new mpox cases in the last week up to Tuesday as African health authorities asked for desperately needed ...
Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors.
In January 2021, SAHPRA authorised under Section 21 of the Medicines and Related Substances Act, a Compassionate Use Access programme, which gave permission to five importers of unregistered Ivermectin in oral solid dosage form and for health facilities to hold bulk stock. The reasoning for this was to thwart the use of illicit and veterinary ...
Medical News for Health Professionals. Perioperative Regional Anesthesia: Less Pain, Fewer Pills. ALS Blood Test Promises Accurate, Earlier Diagnosis. LPA1 Receptor Affects Biomarkers in Pulmonary ...
New Clicks Holdings Limited. Clicks Retail Group is a group of healthcare, beauty, music and lifestyle products retail chains and brands based in South Africa, including Clicks pharmacies. The company was founded in Cape Town by Jack Goldin in 1968 and operates over 670 retail outlets in southern Africa. [1] In 2003, [2] its stock was listed on ...
In fact, the diabetes medication Mounjaro has been on the Food and Drug Administration’s shortage list since late 2022, while Zepbound, a drug approved for weight loss, appeared on the list in ...